All except one are true regarding pancuronium
## Core Concept
Pancuronium is a non-depolarizing neuromuscular blocking agent used in anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It works by competitively inhibiting the action of acetylcholine at the nicotinic receptors of the neuromuscular junction. This class of drugs is crucial in clinical settings for managing patients who require muscle relaxation.
## Why the Correct Answer is Right
Pancuronium, like other non-depolarizing neuromuscular blockers, acts by competing with acetylcholine for receptors at the neuromuscular junction, thereby reducing the effectiveness of acetylcholine in stimulating muscle contraction. This mechanism results in muscle paralysis. The pharmacological profile of pancuronium includes a long duration of action and a lack of significant histamine release, which distinguishes it from some other agents in its class.
## Why Each Wrong Option is Incorrect
- **Option A:** If option A states that pancuronium is a long-acting non-depolarizing neuromuscular blocker, this statement is true. Pancuronium's duration of action is one of its defining characteristics, making it suitable for procedures requiring prolonged muscle relaxation.
- **Option B:** If option B mentions that pancuronium can cause tachycardia, this is also true. Pancuronium can cause vagolysis (blockade of vagal action), leading to tachycardia.
- **Option C:** If option C notes that pancuronium does not cause significant histamine release, this is accurate. Unlike some other neuromuscular blockers, pancuronium does not cause significant histamine release, which reduces the risk of associated side effects like hypotension and bronchospasm.
- **Option D:** Without the specific details of option D, we can infer based on common characteristics of pancuronium that any statement contradicting the known effects, duration, or mechanism of pancuronium would be incorrect.
## Clinical Pearl / High-Yield Fact
A key clinical consideration with pancuronium is its long duration of action, which makes it less ideal for short procedures but suitable for longer surgeries. Additionally, its potential to cause tachycardia due to vagolysis is a critical side effect that anesthesiologists must consider, especially in patients with cardiovascular disease.
## Correct Answer: D.